iShares U.S. Pharmaceuticals ETF $IHE Stock Holdings Lessened by Bank of Montreal Can

Bank of Montreal Can cut its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 13.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,686 shares of the company’s stock after selling 1,076 shares during the quarter. Bank of Montreal Can owned 0.08% of iShares U.S. Pharmaceuticals ETF worth $438,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Truist Financial Corp raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 2.8% during the 2nd quarter. Truist Financial Corp now owns 9,104 shares of the company’s stock valued at $593,000 after purchasing an additional 252 shares in the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter worth $264,000. LPL Financial LLC grew its position in iShares U.S. Pharmaceuticals ETF by 47.6% during the first quarter. LPL Financial LLC now owns 119,866 shares of the company’s stock worth $8,458,000 after buying an additional 38,678 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in iShares U.S. Pharmaceuticals ETF by 20.3% during the first quarter. PNC Financial Services Group Inc. now owns 1,281 shares of the company’s stock worth $90,000 after buying an additional 216 shares in the last quarter. Finally, U.S. Capital Wealth Advisors LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 24.1% during the second quarter. U.S. Capital Wealth Advisors LLC now owns 6,668 shares of the company’s stock valued at $437,000 after purchasing an additional 1,296 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

IHE opened at $81.86 on Wednesday. The firm has a market cap of $658.97 million, a price-to-earnings ratio of 17.75 and a beta of 0.54. iShares U.S. Pharmaceuticals ETF has a twelve month low of $58.97 and a twelve month high of $82.23. The firm’s 50-day simple moving average is $74.41 and its 200-day simple moving average is $69.64.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.